Pharmaceutical Industry Business Confidence Report H2 2016

Publisher Name :
Date: 30-Aug-2016
No. of pages: 50
Inquire Before Buying

Summary

The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H2 2016 (July 2016-December 2016). Companies are slightly optimistic about economic conditions in North America and the Asia-Pacific due to positive momentum in the US, firm domestic demand, and strong government expenditure in India. The pharmaceutical industry is expected to record higher expenditure towards new product development and mergers and acquisitions in H2 2016 as compared to H1 2016. Moreover, executives with business operations in the Asia-Pacific and Europe expect increase in raw material prices in H2 2016 as compared to H1 2016.

Key Findings


  • Economic environment is more favorable in Eastern Europe and Australasia in H2 2016 as compared to H1 2016

  • The majority of respondents communicated optimism about company and industry growth prospects for the next six months

  • Globally, supplier prices of ingredients are anticipated to increase by 2.5% over the next six months

  • Survey results indicate highest increase in spending on new product development in H2 2016 as compared to H1 2016

  • Respondents with business operations in Asia-Pacific are more concerned about the performance of developing economies in H2 2016 as compared to H1 2016

  • Organizations intend to focus on new product development and improving operational efficiency during the next six months


Synopsis

Kable's pharmaceutical Industry Business Confidence Survey H2 2016 examines executives' opinion on the business environment over July-December 2016. It also highlights existing economic conditions, supplier price variations, sales performance, industry and company growth outlook, spending patterns, and key priorities. Additionally, the report provides information categorized by region and presents comparison with H1 2016 wherever applicable.

What else does this report offer?


  • Current state of the global economy: examines prevailing economic conditions globally and across various regions

  • Company and industry growth outlook: provides industry executives' expectations towards the growth prospects of their company and the industry over the next six months

  • Change in customer confidence: analyzes pharmaceutical industry executives' opinion about the change in customer confidence during H2 2016

  • Supplier prices projection: determines expected change in supplier prices across various categories and their impact on business confidence

  • Change in staff headcount and sales performance: tracks expected change in staff headcount and sales for H2 2016 among industry executives globally

  • Significant investment activities: highlights various areas in which industry executives intend to invest over the next six months

  • Business concerns: provides information about potential business concerns indicated by survey respondents for H1 2016

  • Key priorities: identifies the top priorities of industry executives operating in various regions


Reasons To Buy


  • Helps organizations to make effective business strategy decisions by knowing the prevailing business conditions and sentiment within the pharmaceutical industry

  • Organizations will be supported in business expansion decisions by providing information about projected change in sales performance and supplier prices

  • Helps to improve operational efficiency of the organization by knowing about key priorities and the main concerns of pharmaceutical industry executives

  • Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H2 2016

Pharmaceutical Industry Business Confidence Report H2 2016

Table of Contents

Introduction
- Definitions
- Methodology and sample size
- Respondent profile
- Confidence indexes

Economic state, growth prospects and consumer confidence
- Existing economic environment
- Industry and company growth outlook
- Expected change in consumer confidence

Supplier prices, staff headcount and sales performance
- Supplier prices expectations
- Anticipated change in staff head count and sales projections
- Anticipated change in spend on key activities

Business concerns and organizational priorities
- Level of concerns and expected impact
- Significance of potential business priorities

Appendix

List of Figures

Figure 1: Confidence indexes
Figure 2: Current economic condition - Overall (H2 2016) comparison (H2 2016-H1 2016)
Figure 3: Current economic condition - Region
Figure 4: Current economic condition - Region - H2 2016-H1 2016
Figure 5: Current economic condition - Those who operate and do not operate in a region
Figure 6: Industry and company growth prospects - Overall
Figure 7: Industry and company growth prospects - Overall - In detail - comparison (H2 2016-H1 2016)
Figure 8: Industry and company growth prospects - Region
Figure 9: Industry and company growth prospects - Region - H2 2016-H1 2016
Figure 10: Anticipated variation in customer confidence - Overall (H2 2016) comparison (H2 2016-H1 2016)
Figure 11: Anticipated variation in customer confidence - Region
Figure 12: Anticipated variation in customer confidence - Region - H2 2016-H1 2016
Figure 13: Projected change in supplier prices - Raw materials - Overall and regional
Figure 14: Projected change in supplier prices - Raw materials - Regional - H2 2016-H1 2016
Figure 15: Projected change in supplier prices - Semi-finished products - Overall and regional
Figure 16: Projected change in supplier prices - Semi-finished products - Regional - H2 2016-H1 2016
Figure 17: Projected change in supplier prices - Packaging - Overall and regional
Figure 18: Projected change in supplier prices - Packaging - Regional - H2 2016-H1 2016
Figure 19: Projected change in supplier prices - Ingredients - Overall and regional
Figure 20: Projected change in supplier prices - Ingredients - Regional - H2 2016-H1 2016
Figure 21: Staff headcount and sales outlook - Regional - H2 2016-H1 2016
Figure 22: Expenditure projection on key activities - Overall
Figure 23: Expenditure projection on key activities - Overall - H2 2016-H1 2016
Figure 24: Top five business concerns - Region
Figure 25: Business concerns - Overall and regional - A
Figure 26: Business concerns - Overall and regional - A - H2 2016-H1 2016
Figure 27: Business concerns - Overall and regional - B
Figure 28: Business concerns - Overall and regional - B - H2 2016-H1 2016
Figure 29: Top five organizational priorities - Region
Figure 30: Organizational priorities - Overall and region
Figure 31: Organizational priorities - Overall and region - Change compared to H1 2016

  • EMEA (Europe, Middle East and Africa) Recombinant Peptides Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the EMEA Recombinant Peptides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Recombinant Peptides for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux;......
  • EMEA (Europe, Middle East and Africa) Oxyclozanide Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 103
    In this report, the EMEA Oxyclozanide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Oxyclozanide for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle Ea......
  • EMEA (Europe, Middle East and Africa) Montelukast Sodium Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 111
    In this report, the EMEA Montelukast Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Montelukast Sodium for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; ......
  • EMEA (Europe, Middle East and Africa) DHA Powder Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the EMEA DHA Powder market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of DHA Powder for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East......
  • United States Active Pharma Ingredient Market Report 2017
    Published: 24-Mar-2017        Price: US 3800 Onwards        Pages: 117
    In this report, the United States Active Pharma Ingredient market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth......
  • United States Pharmaceutical Grade Fulvic Acid Market Report 2017
    Published: 24-Mar-2017        Price: US 3800 Onwards        Pages: 99
    In this report, the United States Pharmaceutical Grade Fulvic Acid market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • Global Ketoprofen Sales Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Ketoprofen market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ketoprofen for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - South......
  • Global Kaempferol Sales Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 103
    In this report, the global Kaempferol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Kaempferol for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeas......
  • Global Enzyme Inhibitor Sales Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Enzyme Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Enzyme Inhibitor for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs